8-K 1 shire8k0504.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 26, 2001 Shire Pharmaceuticals Group plc -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) England and Wales -------------------------------------------------------------------------------- (State or other jurisdiction of incorporation)
0-29630 N/A -------------------------------------------- ------------------------------------------------ (Commission File Number) (IRS Employer Identification No.)
Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP England -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code 44 1256 894 000 ----------------------------- East Anton, Andover, Hampshire SP10 5RG England -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events On April 26, 2001, Shire Pharmaceuticals Group plc issued the press release attached as Exhibit 99.1 and incorporated by reference herein. Item 7. Financial Statements and Exhibits (c) Exhibits. The following exhibit is filed herewith: 99.1 Press Release dated April 26, 2001 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 4, 2001 SHIRE PHARMACEUTICALS GROUP PLC By: /s/ Angus C. Russell ----------------------------------------- Name: Angus C. Russell Title: Group Finance Director EXHIBIT INDEX Number Description ------ ----------- 99.1 Press Release dated April 26, 2001